title: [Effect of separation characteristics between salbutamol sulfate (SS) particles and model carrier excipients on dry powder for inhalation].
abstract: Most often dry powder for inhalation are formulated as ordered mixtures of a carrier excipient and a micronized drug substance. In the present study, model powder blends were prepared from a mixture of lactose alpha-monohydrate, micro-crystalline cellulose pellets or synthesized sugar as carrier particles, and micronized salbutamol sulfate (SS). These ordered mixtures were aerosolized by the multidose JAGO dry powder inhaler (DPI) and their in vitro deposition properties were evaluated by a twin impinger (TI). The separation force between SS particles and carrier particles was investigated by the centrifuge method. In addition, the use of the air jet sieve (AJS) method was investigated to assess the separation behavior of drug particles from carrier excipient. Powder blends were sieved through a 325 mesh wire screen of an air jet sieve at an air pressure of 1500 Pa. The amount of drug deposited at the carrier surface was analysed before and after the sieving to calculate the percentage of the drug retained. A relationship was found between in vitro deposition properties (fine particle fraction, FPF) and the separation characteristics obtained by the centrifuge method and by the AJS method. The AJS method might be a suitable alternative for evaluating separation of a drug particle from carrier particles and hence can be used for the formulation screening of the dry powder inhalation.
authors.affiliation: Faculty of Pharmacy, Meijo University, Nagoya, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Iida
authors.forename: H
authors.initials: H
authors.lastname: Leuenberger
authors.forename: L M
authors.initials: LM
authors.lastname: Fueg
authors.forename: R
authors.initials: R
authors.lastname: Müller-Walz
authors.forename: K
authors.initials: K
authors.lastname: Danjo
mesh_terms: D000318:Adrenergic beta-Agonists / Q000737:chemistry*; D000420:Albuterol / Q000737:chemistry*; D001993:Bronchodilator Agents / Q000737:chemistry*; D002627:Chemistry, Physical / Q000379:methods; D004337:Drug Carriers; D009330:Nebulizers and Vaporizers; D010316:Particle Size; D011208:Powders
chemical_list: D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D004337:Drug Carriers; D011208:Powders; D000420:Albuterol